Form 4: BeOne Medicines SVP Executes Mandatory Tax Sale

SVP and General Counsel Henry Lee Chan sold 871 American Depositary Shares to satisfy tax withholding obligations related to RSU vesting.

Summary

• Henry Lee Chan, SVP and General Counsel of BeOne Medicines Ltd., sold a total of 871 American Depositary Shares (ADS) on June 8, 2026.
• The sales were conducted in two tranches: 711 shares at a weighted average price of $270.2362 and 160 shares at a weighted average price of $271.2575.
• The transactions were mandatory sales to cover tax withholding obligations resulting from the vesting of restricted share units (RSUs).
• Following these transactions, the reporting person holds 307,047 Ordinary Shares and 0 American Depositary Shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction was a routine, non-discretionary tax withholding event rather than a voluntary divestment.

Positives

• The sale was non-discretionary and executed solely to satisfy tax obligations, indicating no change in the executive's long-term outlook on the company.

Negatives

• Reduction in direct equity holdings of American Depositary Shares by the General Counsel.

Risks

• The reporting person's equity compensation is subject to continued service requirements.
• Unvested securities are subject to specific conditions regarding termination events following a change in control.

Future Outlook

The filing does not provide forward-looking business guidance, as it is a mandatory disclosure of insider transaction activity.

Industry Context

StockSavvy.ai notes that mandatory tax-related sales by executives are standard corporate practice and generally do not signal a lack of confidence in company performance or strategic direction.

Comparison to Industry Standards

• The use of mandatory sell-to-cover programs for tax withholding is a standard governance practice for publicly traded biotechnology and pharmaceutical companies.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a routine tax-related sell-to-cover event.

Next Steps

• Continued vesting of remaining restricted share units on future anniversaries of June 5, 2024.

Key Dates

Keywords

BeOne Medicines, ONC, Form 4, Insider Trading, Tax Withholding, Equity Compensation